Stay informed with the latest litigation news. Explore now

IP Verse

Takeda Pharmaceuticals competitive analysis

Explore the latest publications and patents granted to Takeda Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 12, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Takeda Pharmaceuticals
EP2582812	Jan 24, 2018	Novel Modified Release Dosage Forms Of Xanthine Oxidoreductase Inhibitor Or Xanthine Oxidase Inhibitors	No Opposition Filed Within Time Limit

Explore patent oppositions filed by Takeda Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 18, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3481415	Stable Liquid Fibrinogen	LABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES	Jun 5, 2024
EP3071596	Improved Process For The Preparation Of Immunoglobulin G (Igg)	BIO PRODUCTS LABORATORY	May 29, 2019
EP2345425	Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive Iggs	LABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES	Apr 11, 2019

Discover the latest PTAB cases involving Takeda Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Top competitors of Takeda Pharmaceuticals based on patent oppositions.